Our findings suggest a scenario in which NSCLC cells acquire resistance to Hsp90 inhibitor via activation of IL-6/STAT3 signaling and subsequently Wnt signaling pathway. The gene discussed is STAT3; the disease is non-small cell lung carcinoma.